Communiqués NeuroMetrix, Inc. BOERSE MUENCHEN

Actions

NLZ0

US6412558800

Marché Fermé - BOERSE MUENCHEN Autres places de cotation 21:43:35 28/06/2024			Varia. 5j.	Varia. 1 janv.
3,48 ^EUR	0,00%		-1,14%	+0,29%

15/05	NeuroMetrix, Inc. annonce ses résultats pour le premier trimestre se terminant le 31 mars 2024	CI
19/04	Neurometrix, Inc. nomme Joshua S. Horowitz comme administrateur de classe III au sein du conseil d'administration	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

NeuroMetrix Reports Q1 2024 Business Highlights	15/05	AQ
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value	19/04	AQ
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)	20/03	AQ
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy	14/03	AQ
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia	13/03	AQ
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights	22/02	AQ
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call	15/02	AQ
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value	13/02	AQ
NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024	08/01	AQ
NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)	12/12	AQ
NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy	06/12	AQ
NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)	05/12	AQ
NeuroMetrix Announces One-for-Eight Reverse Stock Split	20/11	AQ
NeuroMetrix to Present at the Emerging Growth Conference on November 1, 2023	30/10/23	AQ
NeuroMetrix Reports Q3 2023 Business Highlights	26/10/23	AQ
NeuroMetrix, Inc. Announces Date for Third Quarter 2023 Business and Financial Highlights Conference Call	23/10/23	AQ
NeuroMetrix and the National Fibromyalgia Association to Collaborate to Improve the Quality of Life for People Living with Fibromyalgia	02/10/23	AQ
NeuroMetrix to Present at the Emerging Growth Conference on October 4, 2023	28/09/23	AQ
NeuroMetrix to Present at the Emerging Growth Conference on September 6, 2023	30/08/23	AQ
NeuroMetrix Reports Q2 2023 Business Highlights	27/07/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués NeuroMetrix, Inc. BOERSE MUENCHEN

Actions

NLZ0

US6412558800

Communiqués

Filtres